Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 42.43mg equivalent to venlafaxine 37.5mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 84.86mg equivalent to venlafaxine 75mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 169.72mg equivalent to venlafaxine 150mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Arrow-Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 254.58mg equivalent to venlafaxine 225mg
Dosage Form: Modified release tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Liconsa SA, Guadalajara, Spain
Product: Fendine Antihistamine
Active Ingredient: Fexofenadine hydrochloride 60mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Cipla Limited, Raigad, India
Product: Fendine Antihistamine
Active Ingredient: Fexofenadine hydrochloride 120mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Cipla Limited, Raigad, India
Dated this 3rd day of December 2010.
JANICE WILSON, Deputy Director-General, Population Health Directorate, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).